Citation only
via Europe PMC
Multimodal prediction of MCI-to-dementia conversion over a two-year window.
Liang TY, Cui X, Adeyosoye M, Simkhada B, Cabrerizo M, Cid RC, Burke SL, Barreto A, Rishe N, Loewenstein DA, Adjouadi M.
GeroScience · 2026
Abstract
Mild cognitive impairment (MCI) represents a heterogeneous clinical state where some individuals remain stable while others progress to dementia. Identification of patients who are at high risk for near-term conversion remains a critical challenge for timely intervention. We developed an explainable multimodal machine-learning framework to predict progression from MCI to dementia within a clinically meaningful two-year period. We analyzed 2008 samples from 828 unique MCI subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI), including cognitive/functional assessments, demographic/genetic variables, and structural MRI features. Subjects were classified as stable MCI (sMCI, n = 1306) or progressive MCI (pMCI, n = 702) based on two-year outcomes. Machine learning algorithms were evaluated on unimodal and multimodal using nested cross-validation, and explainability was assessed using SHapley Additive exPlanations (SHAP) and permutation feature importance. The combination of cognitive assessments, demographics/risk factors and structural MRI features outperformed individual modalities, highlighting the complementary relationship between cognitive-functional decline and neuroanatomical degeneration. The best-performing model, a calibrated XGBoost, achieved a balanced accuracy of 81.28% ± 2.56% during cross-validation and 81.99% (bootstrap mean 81.97%, 95% CI: [78.22%-85.51%]) on an independent held-out test set. Explainable AI analyses identified functional impairment measures (Functional Activities Questionnaire, Clinical Dementia Rating - Sum of Boxes), cognitive performance scores (Alzheimer's Disease Assessment Scale - Cognitive Subscale 11-item version, Alzheimer's Disease Assessment Scale - Cognitive Subscale 13-item version, Mental State Examination), APOE ε4 status, and structural abnormalities within the hippocampus, lateral ventricle, parietal and temporal regions, and amygdala, as the most influential predictors of conversion. Short-term progression from MCI to dementia can be predicted with high accuracy using multimodal information obtained from a single clinical visit. The convergence of cognitive impairment and region-specific neurodegeneration emerged as the strongest indicator of conversion risk.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11357-026-02551-x
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
TY, L., X, C., M, A., B, S., M, C., RC, C., SL, B., A, B., N, R., DA, L., & M., A. (2026). Multimodal prediction of MCI-to-dementia conversion over a two-year window. <em>GeroScience</em>. https://doi.org/10.1007/s11357-026-02551-x
Vancouver
TY L, X C, M A, B S, M C, RC C, et al. Multimodal prediction of MCI-to-dementia conversion over a two-year window. GeroScience. 2026. doi:10.1007/s11357-026-02551-x.
BibTeX
@article{liang2026Multim,
title = {Multimodal prediction of MCI-to-dementia conversion over a two-year window.},
author = {Liang TY and Cui X and Adeyosoye M and Simkhada B and Cabrerizo M and Cid RC and Burke SL and Barreto A and Rishe N and Loewenstein DA and Adjouadi M.},
journal = {GeroScience},
year = {2026},
doi = {10.1007/s11357-026-02551-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Huntington Medical Research Institutes 2011
Open access · US-GOV
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy
Assistance Publique - Hôpitaux de Paris 2007
Open access · US-GOV
A Multicenter Study to Assess Differences Between Circulating Levels of IGF-I and IGFBP-3 in Patients With Sporadic Late-onset Alzheimer's Disease and Control Elderly Subjects.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020
Open access · CC-BY
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
Guangzhou University of Traditional Chinese Medicine 2021
Open access · US-GOV
Exploring Research on Early Warning Indicators of Protein in Patients With Mild Cognitive Impairment and Alzheimer's Disease
Dementia & Neuropsychologia 2016
Open access · CC-BY
Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
University of Haifa 2023
Open access · US-GOV